Health
PharmAust (ASX:PAA) advances testing against COVID-19 – The Market Herald
Clinical-stage oncology PharmAust (ASX:PAA) has advanced its monepantel drugs testing against COVID-19, in the race to find a vaccine for the virus
- Clinical-stage oncology PharmAust (PAA) has signed an agreement with Leiden University Medical (LUMC) for its monepantel drugs testing against COVID-19
- LUMC will test the effects of monepantel and monepantel sulfone on the replication of SARS-CoV-2 in cell lines
- Under the agreement, PharmAust will pay a fee to LUMC and will own all intellectual property results generated from the study
- The study will be overseen by Dr Martijn van Hemert, Principal Investigator of …
Continue Reading
-
Noosa News24 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
Noosa News6 hours agoHow Lily Steele-Park took her rapist to court and won
-
General20 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business11 hours agoFord CEO makes stunning prediction about artificial intelligence